Formation in the presence of C3 nephritic factor (C3NeF) of an alternative pathway C3 convertase containing uncleaved B
- PMID: 992711
- PMCID: PMC1445153
Formation in the presence of C3 nephritic factor (C3NeF) of an alternative pathway C3 convertase containing uncleaved B
Abstract
C3 nephritic factor (C3NeF) interacts with native C3 and B in the absence of D to generate a C3 convertase containing an uncleaved form of B. Dose response studies with C3NeF and B, respectively, revealed incremental C3 inactivation without loss of B. These findings are in agreement with the previous isolation from such reaction mixtures of a 10S complex containing haemolytically inactive C3 and active B and manifesting C3 convertase activity. Functional contamination of C3 with C3b was negated by demonstrating that pretreatment of C3 with C3bINA had no effect on its subsequent interaction with B and C3NeF to generate C3 convertase activity, while pretreatment of C3b eliminated its effective interaction with B and C3NeF. Relatively higher concentrations of C3bINA present during interaction of C3, B and C3NeF suppressed C3 inactivation, indicating its dependence on amplification by utilization of the initial C3b generated. Trace quantities of D were not found by functional analyses of C3, B and C3NeF and pretreatment of these proteins with a concentration of DFP sufficient to suppress D activity had no effect on their effective interaction. The introduction of D to mixtures of C3NeF, B, and C3 resulted in B clevage and more efficient expression of C3 convertase function as defined by a reduced requirement for C3NeF.
Similar articles
-
C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase.J Immunol. 1976 Jan;116(1):1-7. J Immunol. 1976. PMID: 1245733
-
Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.Transplant Proc. 1977 Mar;9(1):729-39. Transplant Proc. 1977. PMID: 325806 Review.
-
The cofactors required by C3 nephritic factor to generate a C3 convertase in vitro.Clin Exp Immunol. 1976 Jun;24(3):474-82. Clin Exp Immunol. 1976. PMID: 939051 Free PMC article.
-
Initiation of C3 cleavage in the alternative complement pathway.J Immunol. 1975 Nov;115(5):1357-61. J Immunol. 1975. PMID: 809512
-
The natural modulation of the amplification phase of complement activation.Transplant Rev. 1976;32:12-25. doi: 10.1111/j.1600-065x.1976.tb00226.x. Transplant Rev. 1976. PMID: 62426 Review.
Cited by
-
Membranoproliferative glomerulonephritis and C3 glomerulopathy in children: change in treatment modality? A report of a case series.Clin Kidney J. 2018 Aug;11(4):479-490. doi: 10.1093/ckj/sfy006. Epub 2018 Feb 28. Clin Kidney J. 2018. PMID: 30094012 Free PMC article.
-
A Narrative Review on C3 Glomerulopathy: A Rare Renal Disease.Int J Mol Sci. 2020 Jan 14;21(2):525. doi: 10.3390/ijms21020525. Int J Mol Sci. 2020. PMID: 31947692 Free PMC article. Review.
-
The properdin pathway: an "alternative activation pathway" or a "critical amplification loop" for C3 and C5 activation?Semin Immunopathol. 2018 Jan;40(1):15-35. doi: 10.1007/s00281-017-0661-x. Epub 2017 Nov 22. Semin Immunopathol. 2018. PMID: 29167939 Review.
-
Modulation of the formation of the human amplification C3 convertase of complement by polycations.Immunology. 1983 Sep;50(1):27-33. Immunology. 1983. PMID: 6554235 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous